Marquette Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-171
| Closed | -$11.8K | – | 232 |
|
|
2023
Q3 | $11.8K | Sell |
171
-39
| -19% | -$2.7K | ﹤0.01% | 211 |
|
|
2023
Q2 | $19.8K | Buy |
+210
| New | +$19.8K | ﹤0.01% | 189 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | – | – | 284 |
|
|
2022
Q2 | $0 | Sell |
5
-2,713
| -100% | – | ﹤0.01% | 340 |
|
|
2022
Q1 | $320K | Buy |
2,718
+6
| +0.2% | +$706 | 0.07% | 74 |
|
|
2021
Q4 | $351K | Hold |
2,712
| – | – | 0.07% | 73 |
|
|
2021
Q3 | $307K | Hold |
2,712
| – | – | 0.07% | 75 |
|
|
2021
Q2 | $281K | Hold |
2,712
| – | – | 0.06% | 74 |
|
|
2021
Q1 | $227K | Hold |
2,712
| – | – | 0.05% | 83 |
|
|
2020
Q4 | $247K | Hold |
2,712
| – | – | 0.06% | 76 |
|
|
2020
Q3 | $216K | Hold |
2,712
| – | – | 0.06% | 65 |
|
|
2020
Q2 | $187K | Hold |
2,712
| – | – | 0.06% | 75 |
|
|
2020
Q1 | $171K | Hold |
2,712
| – | – | 0.07% | 74 |
|
|
2019
Q4 | $211K | Hold |
2,712
| – | – | 0.07% | 70 |
|
|
2019
Q3 | $199K | Hold |
2,712
| – | – | 0.07% | 76 |
|
|
2019
Q2 | $167K | Hold |
2,712
| – | – | 0.06% | 75 |
|
|
2019
Q1 | $173K | Buy |
+2,712
| New | +$173K | 0.06% | 74 |
|